Life Science Analytics Market Size Worth USD 18.12 Billion By 2030

The life science analytics market size is expected to reach USD 18.12 billion by 2030. It is anticipated to grow with a healthy CAGR of 8.25% from 2021 to 2030.

In 2022, the life science analytics market study provides crucial information on market share, market size, growth rate analysis Y-O-Y, production, consumption, and sales analysis for the forecast period 2021 to 2030. The report contains 150+ pages with detailed analysis.

Health care and life sciences analytics is a process of clinical data analysis that offers predictive tools for improved patient care. Analytics play a lead role in the development of various sectors like healthcare, microbiology, and others. The role of analytics in life-science is increasing day by day. The analytics assist the life science firms to transform the raw data into the meaningful insight of life sciences. The data is further utilized by the professionals for the benefit of the patients. Life science analytics helps in the development, discovery, and manufacturing of advanced therapies. Associated courses assist in the firm and government organizations. Life science analytics work on the study which is reported in the form of descriptive, predictive, reporting, and prescriptive based study. Major end-users of these services are medical devices, biotechnology, pharmaceuticals, and others.

What are the Growth Factors?

The growth of the market is mainly associated with its application of advanced analytics. Recently, a high growth rate is seen in the healthcare and medical device sector which directly promotes the growth of the life science analytics market. The use of artificial intelligence and big data analytics is increasing day by day in the healthcare sector, which is also considered as one of the major driving factors which promote the growth of the market. Life science analytics sector is keen to focus on current risks and opportunities for industries.

Technology plays a leading role in current and future development. Rising demand from the end-user industry, especially from the pharmaceutical sector, create prime importance which helps in promoting the growth of the market. However, high cost of implementation followed by a lack of skilled workforce in the area of analytics considered as one of the major restraining factors which affect the growth of the market. Nonetheless, in-depth usage of precision medicine will bring huge growth opportunities within the forecast period.

Regional Snapshots

North America dominated the global life care analytics market. In the United States, life science analytics play a major role in managing the decision of the healthcare professionals. The firm specialized in the direct transformation program on the large scale. Continuous expansion of the healthcare system is one of the major driving factors for the growth of the U.S. market. The huge capacity of spending followed by increasing economic power in the region is also considered the prime factor for the adoption of the medical device companies. The rising entry of public and private partnerships in the domestic market is a key factor for the market. Countries like Germany, France, and the U.K. in Europe capture the major market share.

The rising penetration of IoT things followed with cloud computing services driving the European market. Increasing the data adaptability approach in Latin America is a key factor that promotes the growth of the market. Middle East countries are also showing keen interest in the area of technological adaption.

Market Scope:

Report Highlights Details
Market Size US$ 18.12 Billion by 2030
Growth Rate CAGR of 8.25% from 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Type, Component, Delivery Model, Application, End Users
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

COVID-19 Impact:

The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The life science analytics report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.

Key Players:

The life science analytics market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.

Some of the prominent players in the life science analytics market include:

  • SAS Institute Inc.
  • Oracle Corporation
  • Accenture
  • IBM Corporation
  • Cognizant, SCIO Health Analytics
  • IQVIA
  • Wipro
  • Allscripts Healthcare Solutions
  • Cerner Corporation
  • MaxisIT
  • Optum
  • Microsoft
  • Infosys Limited
  • Cotiviti
  • Others

Market Segmentation

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics
  • Diagnostic Analytics
  • Discovery Analytics

By Component Type

  • Services
  • Software

By Delivery Model

  • On-premise model
  • On-demand model

By Application Type

  • Research & Development
  • Preclinical Trials
  • Clinical Trials
  • Sales & Marketing
  • Regulatory Compliance
  • Supply Chain Optimization
  • Pharmacovigilance

By End Users Type

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third-party Administrators

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Find More Press Releases at https://www.globenewswire.com/en/search/organization/Precedence%2520Research

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Life Science Analytics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Life Science Analytics Market

5.1. Covid-19: Life Science Analytics Industry Impact
5.2. Life Science Analytics Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Life Science Analytics Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Life Science Analytics Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global Life Science Analytics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Life Science Analytics Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Life Science Analytics Market Revenue Market Share by Manufacturer (2015-2020)
7.1.1.3. Life Science Analytics Market Production by Manufacturer (2015-2020)
7.1.1.4. Life Science Analytics Market Production Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Life Science Analytics Market, By Product Type

8.1. Life Science Analytics Market, by Product Type, 2016-2027
8.1.1. Descriptive Analytics
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Predictive Analytics
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Prescriptive Analytics
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Diagnostic Analytics
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Discovery Analytics
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Life Science Analytics Market, By Application

9.1. Life Science Analytics Market, by Application, 2016-2027
9.1.1. Services
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Software
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Life Science Analytics Market, By End-User

10.1. Life Science Analytics Market, by End-User, 2016-2027
10.1.1. On-premise model
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. On-demand model
10.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Life Science Analytics Market, By Technology

11.1. Life Science Analytics Market, by Technology, 2016-2027
11.1.1. Research & Development
11.1.1.1. Market Revenue and Forecast (2016-2027)
11.1.2. Preclinical Trials
11.1.2.1. Market Revenue and Forecast (2016-2027)
11.1.3. Clinical Trials
11.1.3.1. Market Revenue and Forecast (2016-2027)
11.1.4. Sales & Marketing
11.1.4.1. Market Revenue and Forecast (2016-2027)
11.1.5. Regulatory Compliance
11.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 12. Global Life Science Analytics Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue and Revenue Forecast by Product (2016-2027)
12.1.2. Market Revenue and Revenue Forecast by Application (2016-2027)
12.1.3. Market Revenue and Revenue Forecast by End-User (2016-2027)
12.1.4. Market Revenue and Revenue Forecast by Technology (2016-2027)
12.1.5. U.S
12.1.5.1. Market Revenue and Revenue Forecast (2016-2027)
12.1.5.2. Market Revenue and Revenue Forecast (2016-2027)
12.1.6. Canada
12.1.6.1. Market Revenue and Revenue Forecast (2016-2027)
12.1.6.2. Market Revenue and Revenue Forecast (2016-2027)
12.2. Europe
12.2.1. Market Revenue and Revenue Forecast by Product (2016-2027)
12.2.2. Market Revenue and Revenue Forecast by Application (2016-2027)
12.2.3. Market Revenue and Revenue Forecast by End-User (2016-2027)
12.2.4. Market Revenue and Revenue Forecast by Technology (2016-2027)
12.2.5. UK
12.2.5.1. Market Revenue and Revenue Forecast (2016-2027)
12.2.5.2. Market Revenue and Revenue Forecast (2016-2027)
12.2.6. Germany
12.2.6.1. Market Revenue and Revenue Forecast (2016-2027)
12.2.6.2. Market Revenue and Revenue Forecast (2016-2027)
12.2.7. France
12.2.7.1. Market Revenue and Revenue Forecast (2016-2027)
12.2.7.2. Market Revenue and Revenue Forecast (2016-2027)
12.2.8. Rest of EU
12.2.8.1. Market Revenue and Revenue Forecast (2016-2027)
12.2.8.2. Market Revenue and Revenue Forecast (2016-2027)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue and Revenue Forecast by Product (2016-2027)
12.3.2. Market Revenue and Revenue Forecast by Application (2016-2027)
12.3.3. Market Revenue and Revenue Forecast by End-User (2016-2027)
12.3.4. Market Revenue and Revenue Forecast by Technology (2016-2027)
12.3.5. China
12.3.5.1. Market Revenue and Revenue Forecast (2016-2027)
12.3.5.2. Market Revenue and Revenue Forecast (2016-2027)
12.3.6. India
12.3.6.1. Market Revenue and Revenue Forecast (2016-2027)
12.3.6.2. Market Revenue and Revenue Forecast (2016-2027)
12.3.7. Japan
12.3.7.1. Market Revenue and Revenue Forecast (2016-2027)
12.3.7.2. Market Revenue and Revenue Forecast (2016-2027)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Revenue Forecast (2016-2027)
12.3.8.2. Market Revenue and Revenue Forecast (2016-2027)
12.4. LATAM
12.4.1. Market Revenue and Revenue Forecast by Product (2016-2027)
12.4.2. Market Revenue and Revenue Forecast by Application (2016-2027)
12.4.3. Market Revenue and Revenue Forecast by End-User (2016-2027)
12.4.4. Market Revenue and Revenue Forecast by Technology (2016-2027)
12.4.5. Brazil
12.4.5.1. Market Revenue and Revenue Forecast (2016-2027)
12.4.5.2. Market Revenue and Revenue Forecast (2016-2027)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue and Revenue Forecast (2016-2027)
12.4.6.2. Market Revenue and Revenue Forecast (2016-2027)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue and Revenue Forecast by Product (2016-2027)
12.5.2. Market Revenue and Revenue Forecast by Application (2016-2027)
12.5.3. Market Revenue and Revenue Forecast by End-User (2016-2027)
12.5.4. Market Revenue and Revenue Forecast by Technology (2016-2027)
12.5.5. GCC
12.5.5.1. Market Revenue and Revenue Forecast (2016-2027)
12.5.5.2. Market Revenue and Revenue Forecast (2016-2027)
12.5.6. North Africa
12.5.6.1. Market Revenue and Revenue Forecast (2016-2027)
12.5.6.2. Market Revenue and Revenue Forecast (2016-2027)
12.5.7. South Africa
12.5.7.1. Market Revenue and Revenue Forecast (2016-2027)
12.5.7.2. Market Revenue and Revenue Forecast (2016-2027)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue and Revenue Forecast (2016-2027)
12.5.8.2. Market Revenue and Revenue Forecast (2016-2027)

Chapter 13. Company Profiles

13.1. SAS Institute Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2015-2020)
13.1.4. Recent Developments and Strategies
13.2. Oracle Corporation
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2015-2020)
13.2.4. Recent Developments and Strategies
13.3. Accenture
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2015-2020)
13.3.4. Recent Developments and Strategies
13.4. IBM Corporation
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2015-2020)
13.4.4. Recent Developments and Strategies
13.5. Cognizant, SCIO Health Analytics
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2015-2020)
13.5.4. Recent Developments and Strategies
13.6. IQVIA
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2015-2020)
13.6.4. Recent Developments and Strategies
13.7. Wipro
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2015-2020)
13.7.4. Recent Developments and Strategies
13.8. Allscripts Healthcare Solutions
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2015-2020)
13.8.4. Recent Developments and Strategies
13.9. Cerner Corporation
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2015-2020)
13.9.4. Recent Developments and Strategies
13.10. MaxisIT
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2015-2020)
13.10.4. Recent Developments and Strategies

Chapter 14. Research Methodology

14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions

Chapter 15. Appendix

15.1. About Us
15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.